IL6 and COVID-19: Furthermore, miR-29a-3p and -29b-3p depletion has shown to increase circulatory levels of IL-6 [95], the direct activator of the IL-6/STAT3 axis, and in patients with COVID-19 these two miRs were found to be downregulated.